These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The preparation of effector cells for use in the adoptive cellular immunotherapy of human cancer. Yannelli JR J Immunol Methods; 1991 May; 139(1):1-16. PubMed ID: 2040807 [No Abstract] [Full Text] [Related]
13. Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Melief CJ Adv Cancer Res; 1992; 58():143-75. PubMed ID: 1532109 [No Abstract] [Full Text] [Related]
14. Adoptive immunotherapy of urologic tumors. Belldegrun A; Rosenberg SA Cancer Treat Res; 1989; 46():213-33. PubMed ID: 2577191 [No Abstract] [Full Text] [Related]
16. Strategies of lymphocyte activation for the adoptive immunotherapy of metastatic cancer: a review. Strome SE; Krauss JC; Chang AE; Shu S J Hematother; 1993; 2(1):63-73. PubMed ID: 7921967 [No Abstract] [Full Text] [Related]
18. Finding a place for tumor-specific T cells in targeted cancer therapy. Riddell SR J Exp Med; 2004 Dec; 200(12):1533-7. PubMed ID: 15611285 [TBL] [Abstract][Full Text] [Related]
19. Lymphokine-activated killer cell activity of peripheral blood, spleen, regional lymph node, and tumor infiltrating lymphocytes in gastric cancer patients. Karimine N; Nanbara S; Arinaga S; Asoh T; Ueo H; Akiyoshi T J Surg Oncol; 1994 Mar; 55(3):179-85. PubMed ID: 8176929 [TBL] [Abstract][Full Text] [Related]